Germanium is a critical mineral with a deadline problem. It is the standard material for thermal-imaging lenses because it is transparent to infrared, and China refines most of the world’s supply. In December 2024 China banned germanium exports to the US military, and Congress answered with dates written into law: no Chinese germanium in the defense supply chain by December 2027, and Chinese optics out entirely by 2030. For investors, the question is which companies, if any, can actually build a China-free supply chain before the clock runs out.

The supply picture

Germanium is not as scarce as the loudest versions of the story suggest. China dominates refining, but the metal is also sourced from Belgium and Canada, so the “China is the only source” line is an oversimplification. The uncomfortable truth is still real: the bulk of refined germanium runs through China, and the United States has leaned on that supply for its thermal-imaging needs for years.

The uses are concentrated but essential. Germanium lenses sit inside thermal cameras, rifle scopes, missile seekers, and drone optics. The metal also shows up in fiber-optic systems and some high-speed chips. A Pentagon that cannot buy Chinese germanium has to find another way to keep those systems working, which is the entire investment thesis. The germanium explainer covers the metal, the export controls, and the November 27, 2026 expiry date in more detail.

The mine play: Blue Moon Metals

The most direct public exposure to a germanium restart is Blue Moon Metals (BMM), and even that is indirect. Blue Moon owns the Apex project in Utah, a germanium-gallium-copper deposit built around a historic mine that shut down in 1987. Germanium is only one of the three metals at Apex, and the project is better known as the domestic gallium story, but a restart would produce germanium alongside the gallium.

Blue Moon bought Apex from Teck Resources, with Teck taking shares instead of cash. Last month a Pentagon-backed buyer agreed to buy shares at nearly a 32% premium to market. Our teardown reads that as a real but narrow signal: a premium share purchase is one transaction, not a supply contract, and Apex is still an exploration-stage asset rather than a producing mine. The Blue Moon Metals piece lays out the asset base and the risks.

The downstream play is not a miner

The interesting twist is that the Edison Prophecy’s primary pick is not a germanium miner at all. LightPath Technologies is a downstream user that solves the germanium problem by removing the need for it. The company holds an exclusive license to BlackDiamond, a chalcogenide glass developed at the US Naval Research Laboratory that is transparent to infrared but contains no germanium. It can be heated and stamped into precision molds, which cuts cost substantially versus traditional germanium optics.

That is the cleaner way to think about the China-free supply chain. A domestic germanium mine is a long, uncertain project, and there are few pure-play germanium miners to choose from. A domestic material that makes germanium unnecessary in thermal lenses sidesteps the whole problem. The promo’s headline bet is on the second path, not the first.

The honest bottom line

Few pure-play germanium miners exist, and that is the crux of the challenge for anyone looking to invest directly. Most germanium exposure comes through polymetallic projects like Apex, where germanium is one metal among several, or through downstream companies that consume or displace the material. That makes a pure “germanium stocks” basket hard to assemble.

The realistic framing is this: the Pentagon’s deadlines are real, China’s dominance is real, and the incentives to build a domestic alternative are strong. But the companies attempting it are mostly small, early-stage, and years away from production. The disciplined investor treats germanium as a long-dated story with a genuine strategic tailwind and a genuinely uncertain timeline, not as a trade to make on a single deadline.

The reality of the deadline

The 2027 and 2030 deadlines are the part of this story that is hard to dismiss. They are written into US law, which means they do not depend on Chinese goodwill or on the outcome of any single negotiation. A defense supply chain that must be free of Chinese germanium by December 2027 has a hard problem to solve, and the calendar is not generous. The November 27, 2026 expiry of China’s export-control hold is softer, and our teardown treats it as a negotiation artifact rather than a binary cliff, but the legal deadlines are real and fixed.

The practical consequence is that the incentives are aligned for once. The Pentagon wants a domestic answer, Congress has written a timetable, and the companies with a plausible answer are small enough that a single contract can move the needle. That is why the premium purchase in the Blue Moon story is worth watching even though it is only one transaction, not a signed supply agreement.

The risk is that none of the domestic options is ready in time. Exploration-stage mines take years, and a material swap takes time to qualify through defense procurement. The realistic path forward is a mix of byproduct germanium, Canadian and Belgian supply, and germanium-free lenses slowly closing the gap. The pure play on any single answer is where the risk concentrates, and that is the honest warning underneath the headline.

Ready to see the research? Click here to access Matt McCall’s report.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.